Notwithstanding, there are still barriers (scientific, economic, educational, ethical, legal) that need to be overcome prior to the application of
pharmacogenomic technologies towards innovative clinical strategies and optimized therapeutic outcomes.
Not exact matches
Facilitate the introduction of
pharmacogenomics and advanced omics
technologies into the mainstream clinical practice.
The themes of the on demand onsite training revolve around
pharmacogenomics, cancer genomics, economics and Health
Technology Assessment, and genome informatics.
The Pathology Shared Resource facilitates project planning, clinical validation and implementation of novel translational
technology and research in the fields of molecular diagnostics, molecular therapeutics,
pharmacogenomics, quantitative morphologic image analysis and immunohistochemistry (IHC) in a CLIA - certified, CAP - accredited laboratory ensuring optimal clinical quality assurance.